Recurrence of a gonadal stromal cell tumor (Sertoli Leydig cell with heterologous elements) in a teenager.

Abstract

An unusual case of a moderately well-differentiated, encapsulated, Sertoli Leydig cell tumor with heterologous elements recurring 3 years after a conservative unilateral oophorectomy in a 15-year-old female is reported. This is the first case report of a metastatic Sertoli Leydig cell tumor with mucinous heterologous elements. A relative lack of uniformly accepted histological criteria of these tumors makes prognosis difficult to access. The optimal therapy for recurrent Sertoli Leydig cell tumor is unknown. Initial plans of management of this rare neoplasm, follow-up, and current concepts of treatment of recurrences will be discussed.

• Authors: T Nolan, D G Gallup, D R Dufour
• Journal: Gynecologic oncology (Gynecol Oncol) Vol. 15 Issue 1 Pg. 111-9 (Feb 1983) ISSN: 0090-8258 [Print] United States
• PMID: 6822363 (Publication Type: Case Reports, Journal Article, Research Support, Non-U.S. Gov't)

Chemical References

• Antineoplastic Agents

Topics

• Adolescent
• Antineoplastic Agents (administration & dosage)
• Castration
• Drug Therapy, Combination
• Female
• Humans
• Leydig Cell Tumor (drug therapy, pathology, surgery)
• Neoplasm Recurrence, Local (pathology)
• Ovarian Neoplasms (drug therapy, pathology, surgery)
• Prognosis
• Sertoli Cell Tumor (drug therapy, pathology, surgery)